1,n(2)-propanodeoxyguanosine has been researched along with Kaposi Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, G; Huang, Y; Johnson, F; Miller, H; Moriya, M; Torres, MC; Yang, IY | 1 |
| Hecht, SS; Lao, Y; Moriya, M; Stein, S; Yang, IY | 1 |
2 other study(ies) available for 1,n(2)-propanodeoxyguanosine and Kaposi Disease
| Article | Year |
|---|---|
Mutagenesis by acrolein-derived propanodeoxyguanosine adducts in human cells.
Topics: Acrolein; Base Pair Mismatch; Deoxyguanosine; DNA Adducts; DNA Damage; DNA Primers; DNA Repair; DNA Replication; Escherichia coli; Genetic Vectors; HeLa Cells; Humans; Mutagenesis; Xeroderma Pigmentosum | 2002 |
Genotoxicity of acetaldehyde- and crotonaldehyde-induced 1,N2-propanodeoxyguanosine DNA adducts in human cells.
Topics: Acetaldehyde; Aldehydes; Cell Line; Deoxyguanosine; DNA Adducts; DNA Damage; Humans; Mutagens; Oligonucleotides; Plasmids; Point Mutation; Stereoisomerism; Transfection; Xeroderma Pigmentosum | 2006 |